Global Pharmaceutical Excipients Market

Pharmaceutical Excipients Market Size, Share, Growth Analysis, By Product (Organic Chemicals, Inorganic Chemicals), By Formulation (Oral Formulations, Topical Formulations), By Functionality (Fillers & Diluents, Suspending & Viscosity Agents), By Functionality Application (Infectious Diseases, Endocrinology), By End User (Stabilizers, Taste Masking), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2120 | Region: Global | Published Date: September, 2024
Pages: 242 | Tables: 126 | Figures: 77

Pharmaceutical Excipients Market News

 

  • In October 2023, a new range of pharmaceutical excipients was launched at the CPHI Barcelona event by Clariant, a renowned chemicals company. VitiPure® excipients were aimed at solving the challenges of bioavailability of active pharmaceutical ingredients for pharmaceutical manufacturers.  
  • In November 2021, three new pharmaceutical excipients were launched by Gattefossé, a leading provider of pharmaceutical excipients. Labrafac MC60, Gelucire 59/14 and Emulfree Duo were launched after they cleared all regulatory requirements and helped the company strengthen its stance in the global market.  
  • Back in July 2021, Pharmacel sMCC 90, a silicified microcrystalline cellulose (MCC) was launched by a leading pharmaceutical excipient provider known as DFE Pharma. The new excipient solution was developed for oral dosage formulations. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Pharmaceutical Excipients Market size was valued at USD 9.48 billion in 2022 and is poised to grow from USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Pharmaceutical excipients companies should invest heavily in R&D to develop and market new products that help them stand out from the competition. Partnerships, mergers, and acquisitions are also expected to be preferred strategies for pharmaceutical excipients providers in the future. Providing affordable yet effective pharmaceutical excipients could also help pharmaceutical excipients providers maximize their business scope in underdeveloped and developing countries with limited healthcare expenditure.  'BASF SE (Germany) ', 'Ashland Inc. (US) ', 'Evonik Industries AG (Germany) ', 'Kerry Group PLC (Ireland) ', 'Roquette Frères (France) ', 'Merck KGaA (Germany) ', 'Associated British Foods PLC (UK) ', 'ADM (US) ', 'Wacker Chemie AG (Germany) ', 'Air Liquide (France) ', 'Dow (US) ', 'Lubrizol Corporation (Berkshire Hathaway) (US) ', 'Colorcon (US) ', 'DFE Pharma (Germany) ', 'Innophos (US) ', 'J. Rettenmaier & Söhne GmbH + Co KG (Germany) ', 'Actylis (US) ', 'Meggle GmbH & Co. KG (Germany) ', 'Fuji Chemical Industries Co., Ltd. (Japan) ', 'Corel Pharma Chem (India) ', 'Biogrund GmbH (Germany) ', 'Nitika Pharmaceutical Specialties Pvt. Ltd. (India) ', 'R.T. Vanderbilt Holding Company, Inc. (US) ', 'Beneo (Germany)'

Costs of drugs and pharmaceuticals are reaching all-time highs around the world and this has led to the high popularity of generic medicine. Growing emphasis on increasing healthcare accessibility and reducing healthcare costs is projected to bolster the demand for generic medicine thereby also favoring pharmaceutical excipients market development.   

Natural Pharmaceutical excipients: Pharmaceutical excipients companies should focus on incorporating natural and biodegradable ingredients in their offerings to cater the evolving consumer preferences. Growing number of people abstaining from chemical-based medications will push the demand for drugs with natural pharmaceutical excipients and provide new opportunities for market players in the long run.    

North America is estimated to lead the global pharmaceutical excipients demand outlook. Presence of key pharmaceutical excipients manufacturers, high demand for pharmaceuticals, and robust spending on medical research are key factors helping the dominance of this region. Rising popularity of biologics and generic drugs to reduce healthcare costs in this region is also expected to create new opportunities for pharmaceutical excipients companies in the future. Canada and the United States remain the top markets for pharmaceutical excipients companies in the North American region. Growing incidence of chronic illnesses in this region will also favor the demand for pharmaceutical excipients going forward. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Pharmaceutical Excipients Market

Report ID: SQMIG35I2120

$5,300
BUY NOW GET FREE SAMPLE